2 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 2, Unknown 2, Not yet recruiting 1, Recruiting 1 |
Follow mecobalamin: new trials by email Literature Review of mecobalamin trials Research Report on mecobalamin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hand and Foot Bath for Taxane-Induced Peripheral Neurotoxicity Traditional Chinese medicine (TCM) hand and foot baths, Methylcobalamin (methylB12) - Breast Cancer | Phase 4 | Not yet recruiting | Peking University Cancer Hospital & Institute | 78 | 2026-02-01 | 2026-01-20 |
| Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment Anti-VEGF drug, Mecobalamin 5 MG, Placebo - Retinal Vein Occlusion (RVO) | Phase 4 | Recruiting | First Affiliated Hospital of Chongqing Medical University | 120 | 2025-08-01 | 2026-02-27 |
| Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury Mecobalamin, Ceftriaxone Sodium, Saline - Sepsis, Liver Dysfunction | Phase 4 | Unknown | Sichuan Provincial People's Hospital | 40 | 2024-01-15 | 2024-01-24 |
| Efficacy of L-methylfolate and Methylcobalamine in Treating Resistant Hypertension Associated With Elevated Serum Homocysteine in Hemodialysis Patients. L-Methyl Folate and methylcobalamine - End Stage Renal Disease, Hypertension, Renal | Phase 4 | Completed | Alexandria University | 51 | 2023-04-01 | 2025-01-13 |
| Effects of Epalrestat on Peripheral Neuropathy and Central Nervous System in Diabetic Patients Epalrestat,Mecobalamin, Mecobalamin - Diabetes | Phase 4 | Unknown | Xiangya Hospital of Central South University | 72 | 2022-01-01 | 2022-01-11 |
| The Role of Methycobalamin in Early Dementia Patients With Vitamin B12 Deficiency and Hyperhomocysteinaemia. Mecobalamin - Dementia With Vitamin B12 Deficiency | Phase 4 | Completed | Eisai Co., Ltd. | 2003-03-01 | 2019-02-19 |
Breast Neoplasms (1) · Diabetes Mellitus (1) · Hypertension, Renal (1) · Kidney Failure, Chronic (1) · Liver Diseases (1) · Macular Edema (1) · Retinal Vein Occlusion (1) · Sepsis (1)
Alexandria University (1) · Eisai Co., Ltd. (1) · First Affiliated Hospital of Chongqing Medical University (1) · Peking University Cancer Hospital & Institute (1) · Sichuan Provincial People's Hospital (1) · Xiangya Hospital of Central South University (1)
China (4) · Egypt (1)
Chun Pan, ph.D (1) · Hanan M El-gowelli, PhD (1) · Hesham A Elghoneimy, PhD (1) · Mohamed S Salem, PharmD (1) · Noha A Hamdy, PhD (1) · Romeo Chu (1)
PMID 11562419, PMID 15385656, PMID 18587236, PMID 41580678, PMID 42486517